investors

Struggling Amarin jousts with activist investor Sarissa as board vote nears
Struggling Amarin jousts with activist investor Sarissa as board vote nears
Fierce Pharma
Amarin
Vascepa
investors
Flag link:
Bayer under investor pressure to speed up CEO changeover
Bayer under investor pressure to speed up CEO changeover
Reuters
Bayer
investors
Pharma CEOs
Werner Baumann
Flag link:
Why Moderna and BioNTech Tumbled on Thursday
Why Moderna and BioNTech Tumbled on Thursday
Motley Fool
Moderna Therapeutics
BioNTech
COVID-19
vaccines
investors
Flag link:
Novo Nordisk comes out clean in $1.8B investor lawsuit alleging insulin misdirection
Novo Nordisk comes out clean in $1.8B investor lawsuit alleging insulin misdirection
Fierce Pharma
Novo Nordisk
investors
legal
insulin
diabetes
Flag link:
Testimony: Holmes Offered to Buy Out Investor Seeking "Straight Answers"
Testimony: Holmes Offered to Buy Out Investor Seeking "Straight Answers"
BioSpace
Theranos
Elizabeth Holmes
legal
fraud
investors
Flag link:
Trouble builds for Merck's $11.5B Acceleron buy as activist investor behind Gilead's Immunomedics deal says too early, too cheap
Trouble builds for Merck's $11.5B Acceleron buy as activist investor behind Gilead's Immunomedics deal says too early, too cheap
Fierce Pharma
Merck
Acceleron
M&A
investors
Avoro Capital
Flag link:
Covid has made biotech companies the hot new tech sector as investor demand drives record IPOs
Covid has made biotech companies the hot new tech sector as investor demand drives record IPOs
CNBC
biotech
IPOs
investors
Flag link:
Biotech Company That Botched Vaccines Faces Investor Revolt
Biotech Company That Botched Vaccines Faces Investor Revolt
NY Times, NY
Emergent BioSolutions
investors
vaccines
COVID-19
Flag link:
GSK backs CEO Walmsley, rejecting Elliott’s call to change board
GSK backs CEO Walmsley, rejecting Elliott’s call to change board
Pharmaforum
GSK
Pharma CEOs
Emma Walmsley
Elliott Management
investors
Flag link:
Activist Investor Continues Campaign Against Walmsley, GSK Leadership
Activist Investor Continues Campaign Against Walmsley, GSK Leadership
BioSpace
GSK
Emma Walmsley
investors
Flag link:
GSK outlines ambitious 10-year plan, but hits investors' near-term outlook
GSK outlines ambitious 10-year plan, but hits investors' near-term outlook
BioPharma Dive
GSK
investors
cancer
Immune
infectious disease
Flag link:
Pair of R&D updates bolster GSK ahead of investor meeting
Pair of R&D updates bolster GSK ahead of investor meeting
Pharmaforum
GSK
COVID-19
sotrovimab
Halozyme
investors
Flag link:
Glaxo set to ask investors to keep the faith
Glaxo set to ask investors to keep the faith
EP Vantage
GSK
investors
Flag link:
Is Illumina Making an $8 Billion Blunder?
Is Illumina Making an $8 Billion Blunder?
Motley Fool
Illumina
Grail
M&A
diagnostics
investors
Flag link:
Alexion shoots down 'proactive' sale demand from activist investor
Alexion shoots down 'proactive' sale demand from activist investor
Fierce Pharma
Alexion
investors
M&A
Flag link:
6 Things About Biopharma to Be Thankful For
6 Things About Biopharma to Be Thankful For
BioSpace
innovation
vaccines
investors
Flag link:
Novo faces shareholder suit over insulin sales disclosures
Novo faces shareholder suit over insulin sales disclosures
Biopharma Dive
Novo Nordisk
insulin
investors
Flag link:
Strength of Oncology Pipeline Touted at Merck’s First Investor Day in Five Years
Strength of Oncology Pipeline Touted at Merck’s First Investor Day in Five Years
BioSpace
Merck
Keytruda
investors
Flag link:
Investor day prep at Merck includes a new strategy to pick up the pace on M&A
Investor day prep at Merck includes a new strategy to pick up the pace on M&A
Endpoints
Merck
investors
Keytruda
cancer
M&A
Flag link:
Is CEO pay linked to drug prices? Curious investors failed their campaign to find out
Is CEO pay linked to drug prices? Curious investors failed their campaign to find out
Fierce Pharma
Big Pharma
investors
drug pricing
executive pay
Flag link:

Pages